Philippines - English - FDA (Food And Drug Administration)

n/a; importer: n/a; distributor: starpharm, inc. - ascorbic acid , zinc - tablet - 500 mg (equivalent to 562.5 mg sodium ascorbate)/ 10 mg (equivalent 27.5 mg zinc sulfate monohydrate)

Philippines - English - FDA (Food And Drug Administration)

starpharm inc. - ascorbic acid , zinc - syrup - 100mg/ 10mg per 5ml

United States - English - NLM (National Library of Medicine)

austarpharma llc - carbamazepine (unii: 33cm23913m) (carbamazepine - unii:33cm23913m) - carbamazepine is indicated for use as an anticonvulsant drug. evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. partial seizures with complex symptomatology (psychomotor, temporal lobe). patients with these seizures appear to show greater improvement than those with other types. 2. generalized tonic-clonic seizures (grand mal). 3. mixed seizure patterns which include the above, or other partial or generalized seizures. absence seizures (petit mal) do not appear to be controlled by carbamazepine (see precautions, general). carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. beneficial results have also been reported in glossopharyngeal neuralgia. this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains. carbamazepine should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug, or known sensitivity to any of the tricyclic compounds, such as amitriptyline, desipramine, imipramine, protriptyline, nortriptyline, etc. likewise, on theoretical grounds its use with monoamine oxidase (mao) inhibitors is not recommended. before administration of carbamazepine, mao inhibitors should be discontinued for a minimum of 14 days, or longer if the clinical situation permits. coadministration of carbamazepine and nefazodone may result in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. coadministration of carbamazepine with nefazodone is contraindicated. no evidence of abuse potential has been associated with carbamazepine, nor is there evidence of psychological or physical dependence in humans.

United States - English - NLM (National Library of Medicine)

austarpharma llc - methocarbamol (unii: 125od7737x) (methocarbamol - unii:125od7737x) - methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. methocarbamol does not directly relax tense skeletal muscles in man. methocarbamol is contraindicated in patients hypersensitive to methocarbamol or to any of the tablet components. methocarbamol may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving a motor vehicle. patients should be cautioned about operating machinery, including automobiles, until they are reasonably certain that methocarbamol therapy does not adversely affect their ability to engage in such activities. safety and effectiveness of methocarbamol in pediatric patients below the age of 16 have not been established.

Singapore - English - HSA (Health Sciences Authority)

mundipharma pharmaceuticals pte. ltd. - obstetrics & gynaecology - betadine™ bv gel is a clear gel intended to be applied into the vagina and has been clinically tested to shown to • treat bacterial vaginosis (bv), restore vaginal flora balance and normalize vaginal ph. • provide rapid resolution of symptoms including fishy vaginal odour and discharge. • prevent recurrent bv and its symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

starpharma pty ltd - 47601 - vaginal flora gel - astodrimer sodium (fleurstat; vivagel?), in the form of a gel applied by the user into the vagina: once daily for seven days, for topical treatment and rapid relief of bacterial vaginosis (bv), including unpleasant vaginal odour and discharge, helping to normalise vaginal ph and restore the normal vaginal flora balance; once every second day, for prevention of recurrent bv, including prevention of unpleasant vaginal odour and discharge, helping to maintain normal vaginal ph and vaginal flora balance. after application, the device cannot be reused.

Philippines - English - FDA (Food And Drug Administration)

starpharm, inc - buclizine hydrochloride , vitamin b-complex , iron (see reverse for formulation) - syrup - each 5 ml contains: buclizine hydrochloride thiamine hydrochloride (vit. bi) pyridoxine hydrochloride (vit. b6) cyanocobalamin (vit. b12) ferrous sulfate (eq. to 10 mg elemental iron) 5 mg 10 mg

Philippines - English - FDA (Food And Drug Administration)

starpharm, inc. - guaifenesin , salbutamol (as sulfate) - syrup - 5mg/ 10mg per 5ml

Philippines - English - FDA (Food And Drug Administration)

starpharm inc - mefenamic acid - suspension, oral - 50mg/5ml

Philippines - English - FDA (Food And Drug Administration)

starpharm, inc. - phenylephrine hydrochloride , brompheniramine maleate - syrup (oral drops) - 2.5mg/ 1mg per ml